Relief Therapeutics Holding SA
SIX:RLF
Relief Therapeutics Holding SA
SIX:RLF
Price:
1.06
CHF
-63.26%
Market Closed
Market Cap:
CHf437m
Income Statement
Earnings Waterfall
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
Income Statement
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
Currency: CHF
| Dec-2009 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
14
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
7
+98%
|
6
-7%
|
6
-4%
|
6
+3%
|
9
+42%
|
8
-2%
|
4
-52%
|
|
| Gross Profit | |||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
3
N/A
|
5
+100%
|
5
-6%
|
5
-7%
|
4
-5%
|
6
+41%
|
6
-4%
|
2
-58%
|
|
| Operating Income | |||||||||||||||||||
| Operating Expenses |
(24)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(20)
|
(31)
|
(36)
|
(44)
|
(30)
|
(23)
|
(24)
|
(18)
|
(13)
|
(22)
|
|
| Selling, General & Administrative |
(9)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(6)
|
(10)
|
(16)
|
(20)
|
(24)
|
(25)
|
(19)
|
(14)
|
(10)
|
(8)
|
|
| Research & Development |
(11)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(3)
|
(14)
|
(19)
|
(19)
|
(21)
|
(12)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(4)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(2)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Other Operating Expenses |
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
2
|
(1)
|
(3)
|
1
|
1
|
10
|
9
|
0
|
0
|
0
|
(11)
|
|
| Operating Income |
(10)
N/A
|
(1)
+90%
|
(2)
-65%
|
(1)
+36%
|
(1)
+55%
|
(1)
-22%
|
(1)
-41%
|
(2)
-83%
|
(20)
-1 185%
|
(31)
-53%
|
(34)
-8%
|
(38)
-15%
|
(26)
+33%
|
(18)
+29%
|
(20)
-8%
|
(12)
+38%
|
(7)
+38%
|
(20)
-164%
|
|
| Pre-Tax Income | |||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
1
|
0
|
(0)
|
|
| Non-Reccuring Items |
(2)
|
0
|
0
|
0
|
0
|
0
|
(11)
|
0
|
15
|
1
|
(1)
|
(9)
|
(26)
|
(70)
|
(91)
|
(39)
|
(12)
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(12)
N/A
|
(1)
+91%
|
(2)
-78%
|
(1)
+37%
|
(0)
+65%
|
(1)
-46%
|
(12)
-1 904%
|
(2)
+85%
|
(6)
-251%
|
(31)
-391%
|
(36)
-16%
|
(49)
-38%
|
(54)
-11%
|
(90)
-66%
|
(112)
-24%
|
(52)
+54%
|
(19)
+62%
|
(20)
-3%
|
|
| Net Income | |||||||||||||||||||
| Tax Provision |
0
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
5
|
3
|
(2)
|
(0)
|
1
|
2
|
4
|
10
|
14
|
5
|
2
|
3
|
|
| Income from Continuing Operations |
(12)
|
(1)
|
(3)
|
(2)
|
(0)
|
(1)
|
(7)
|
1
|
(8)
|
(31)
|
(35)
|
(47)
|
(51)
|
(81)
|
(98)
|
(46)
|
(17)
|
(17)
|
|
| Net Income (Common) |
(12)
N/A
|
(1)
+91%
|
(3)
-170%
|
(2)
+24%
|
(0)
+80%
|
(1)
-44%
|
(7)
-1 090%
|
1
N/A
|
(8)
N/A
|
(31)
-293%
|
(35)
-13%
|
(47)
-34%
|
(51)
-9%
|
(81)
-59%
|
(98)
-22%
|
(46)
+53%
|
(17)
+63%
|
(17)
+0%
|
|
| EPS (Diluted) |
-0.19
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-1.3
N/A
|
-0.01
+99%
|
-3.86
-38 500%
|
-4.47
-16%
|
-4.81
-8%
|
-7.29
-52%
|
-8.35
-15%
|
-3.68
+56%
|
-1.37
+63%
|
-1.36
+1%
|
|
Switch to:
Switch to:
See Also
Discover More
